The association between cyclosporine treatment and development of C-ALCL and other CD30+ lymphoproliferative disorders has previously been reported in patients with atopic dermatitis, psoriasis, and transplant patients. This evidence concerns the gene TNFRSF8 and lymphoproliferative syndrome.